Pitcairn’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $208K | Sell |
16,992
-643
| -4% | -$7.87K | 0.01% | 665 |
|
|
2025
Q1 | $253K | Buy |
17,635
+345
| +2% | +$4.94K | 0.02% | 633 |
|
|
2024
Q4 | $275K | Buy |
17,290
+2,074
| +14% | +$33K | 0.02% | 609 |
|
|
2024
Q3 | $366K | Sell |
15,216
-2,080
| -12% | -$50K | 0.02% | 535 |
|
|
2024
Q2 | $345K | Buy |
17,296
+1,356
| +9% | +$27K | 0.02% | 543 |
|
|
2024
Q1 | $317K | Buy |
15,940
+1,606
| +11% | +$32K | 0.02% | 563 |
|
|
2023
Q4 | $322K | Sell |
14,334
-473
| -3% | -$10.6K | 0.02% | 522 |
|
|
2023
Q3 | $299K | Sell |
14,807
-1,338
| -8% | -$27.1K | 0.03% | 503 |
|
|
2023
Q2 | $413K | Buy |
16,145
+4,561
| +39% | +$117K | 0.03% | 424 |
|
|
2023
Q1 | $345K | Buy |
11,584
+566
| +5% | +$16.8K | 0.03% | 458 |
|
|
2022
Q4 | $298K | Sell |
11,018
-806
| -7% | -$21.8K | 0.03% | 469 |
|
|
2022
Q3 | $258K | Buy |
11,824
+764
| +7% | +$16.7K | 0.03% | 472 |
|
|
2022
Q2 | $302K | Buy |
11,060
+200
| +2% | +$5.46K | 0.03% | 433 |
|
|
2022
Q1 | $364K | Buy |
10,860
+92
| +0.9% | +$3.08K | 0.03% | 453 |
|
|
2021
Q4 | $373K | Buy |
10,768
+2,162
| +25% | +$74.9K | 0.02% | 450 |
|
|
2021
Q3 | $268K | Buy |
+8,606
| New | +$268K | 0.02% | 531 |
|